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Two variable number tandem repeats (VNTRs) in the human
serotonin transporter gene, SLC6A4 (the structure is shown in
Fig. 1a) have been implicated in the pathophysiology of
many CNS-related disorders (reviewed in Haddley et al.
2007). The ﬁrst identiﬁed was a bi-allelic 43 bp insertion/
deletion 1.2 kb upstream of the transcription start site,
termed the SLC6A4 gene-linked polymorphic region (LPR)
(Heils et al. 1996; Lesch et al. 1996). The most commonly
occurring LPR variants contain 14 (short, s) or 16 (long, l)
copies of a 22–23 bp repeat (Fig. 1b) (Heils et al. 1997;
Nakamura et al. 2000). Recent clinical studies indicated that
an A/G single nucleotide polymorphism (SNP) in the l-allele
of the LPR VNTR could affect SLC6A4 mRNA expression
(Hu et al. 2005; Wendland et al. 2006). The second VNTR
found in intron 2 comprises most commonly 9, 10 or 12
copies of a 16–17 bp repeat (Stin2.9, Stin2.10 and Stin2.12
VNTRs respectively) (Battersby et al. 1996; Ogilvie et al.
1996). We and others have previously demonstrated that
these Stin2 VNTRs support differential gene expression
in vitro (Heils et al. 1996; Lesch et al. 1996; Lovejoy et al.
2003; Klenova et al. 2004; Roberts et al. 2007) and during
neural development in transgenic mice (MacKenzie and
Quinn 1999). The potential contribution of genomic variation
to direct differential SLC6A4 gene expression was further
supported by the identiﬁcation of other SNPs in the middle
of the ﬁrst intron; rs16965628 and rs2020933 that showed
a signiﬁcant correlation with the allelic transcript ratio of
SLC6A4, therefore, contributing to the differential expression
of the SLC6A4 gene (Martin et al. 2007).
Many studies have linked these VNTRs with disorders
including increased risk of developing depression (Cervilla
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Abstract
Two distinct variable number tandem repeats (VNTRs) within
the human serotonin transporter gene (SLC6A4) have been
implicated as predisposing factors for CNS disorders. The
linked polymorphic region in the 5¢-promoter exists as short
(s) and long (l) alleles of a 22 or 23 bp elements. The sec-
ond within intron 2 (Stin2) exists as three variants containing
9, 10 or 12 copies of a 16 or 17 bp element. These VNTRs,
individually or in combination, supported differential reporter
gene expression in rat neonate prefrontal cortical cultures.
The level of reporter gene activity from the dual VNTR
constructs indicated combinatorial action between the two
domains. Chromatin immunoprecipitation demonstrated that
both these VNTR domains can bind the CCCTC-binding
factor and this correlated with the ability of exogenously
supplied CCCTC-binding factor to modulate the expression
supported by these reporter gene constructs. We suggest
that the potential for interaction between multiple polymor-
phic domains should be incorporated into genetic association
studies.
Keywords: behaviour, CCCTC-binding factor, human sero-
tonin transporter, polymorphism, variable number tandem
repeat.
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(Lesch et al. 1996; Hariri et al. 2002), predisposition to
suicide or depression following stressful life events (Caspi
et al. 2003; Zalsman et al. 2006) and a predisposition to
obsessive compulsive disorder (Bengel et al. 1999). How-
ever, these ﬁndings were not always reproducible in inde-
pendentstudies (Rees et al. 1997;Hoeheet al. 1998). Various
meta-analyses suggested no signiﬁcant allelic frequency
association of the Stin2 VNTRs with affective disorders but
they did favour an association of the LPR VNTR with these
disorders (Cho et al. 2005; Lasky-Su et al. 2005).
We have previously shown that the transcription CCCTC-
binding factor (CTCF) is a regulator of Stin2 VNTR
function (Klenova et al. 2004; Roberts et al. 2007). CTCF
is a DNA-binding protein with a role in transcriptional
activation or silencing in a context-dependent fashion and
may also act as an insulator in epigenetic remodelling
(Ohlsson et al. 2001; Klenova et al. 2002). There are several
potential high afﬁnity CTCF binding sites present in the
LPR (Fig. 1b) and we hypothesised that, as transcriptional
domains, the LPRVNTR and Stin2 VNTR can act in concert
to modulate SLC6A4 gene expression, and that CTCF may
be one factor to coordinate such activity. To support such a
hypothesis we have addressed the ability of the VNTRs to
function together in modulating reporter gene activity in
neuronal cultures and assessed if such function was regu-
lated by CTCF.
Experimental procedures
Comprehensive details of the material and methods are given
online in Appendix S1.
Generation of reporter gene constructs
The promoter LPR and Stin2 VNTR fragments were ampliﬁed by
PCR using the primers: forward 5¢-GGGGTACCCCTGGCGTTG
CCGCTCTGAATGC-3¢ and reverse 5¢-CCGCTCGAGCGGAGG
GACTGAGCTGGACAACCAC-3¢ and forward 5¢-ATGGCGCG
CCGGTACCTCACAGGCTGCGAGTAGA-3¢ and reverse 5¢-AA
CGGCGCGCCTCGAGTGGCCTCTCAAGAGGA-3¢ respectively.
VNTR fragments were cloned into a modiﬁed renilla luciferase
reporter vector [modiﬁed phRLSV40 (Guindalini et al. 2006)], such
that each individual promoter LPR fragment was placed upstream of
a minimal SV40 promoter (creating phRL_long and phRL_short)
and each individual Stin2 VNTR fragment was placed within a
synthetic intron located upstream of the renilla luciferase coding
sequences (creating phRL_Stin2.9, phRL_Stin2.10 and phRL_
Stin2.12). Dual constructs termed: L9, L10, L12, S9, S10 and S12
were created such that combinations of alleles from the two VNTRs
were present at their respective positions within the plasmid
(Fig. 1c).
Reverse transcription PCR
Total RNA was extracted from rat prefrontal cortical cells with
Trizol reagent (Invitrogen, Paisley, UK) and reverse-transcribed
to cDNA using Reverse Transcription System (Promega, South-
ampton, UK) following manufacturer’s instructions. PCR was
performed to conﬁrm SLC6A4 mRNA expression using the
primers forward 5¢-TTCCTCCTGTCCGTCATTGG-3¢ and reverse
5¢-GGTGGATCTGCAGGACATGG-3¢ from exons 1 and 4
respectively.
Primary cell culture, transient transfections and luciferase assays
Male Wistar albino rats (2 to 7-day old) were used to generate
primary cortical cultures. All animals were culled under local and
national schedule one guidelines. Reporter constructs (1 lg) or
modiﬁed phRLSV40 (1 lg) and modiﬁed pMLuc-2 (expressing
Fireﬂy luciferase as an internal control) were co-transfected using
ExGen500 in vitro transfection reagent following manufacturer’s
guidelines (Fermentas, York, UK). For co-transfections with CTCF,
cells were transfected with 1 lg of reporter gene and 1 lgo f
expression vector pCI-CTCF (Klenova et al. 2004), or to standard-
ise total DNA concentration, pGL3basic (Promega). Cells were
harvested and assayed using the Dual Luciferase Reporter Assay
System (Promega) and luminescence was measured using a Glomax
96 microplate luminometer (Promega). Mean and SEM were
calculated from the results of three independent experiments
performed in triplicate.
Statistical analysis
Data were subjected to statistical analysis using one-way ANOVA and
a signiﬁcance level of 0.05. The Dunnett’s (two-sided) t method was
used as a post hoc test to account for multiple comparisons.
Chromatin immunoprecipitation
DNA and protein from 10
7 JAr cells (human placental choriocar-
cinoma) were cross-linked with 1% formaldehyde and mixed
thoroughly at 20 C for 10 min. Chromatin immunoprecipitation
(ChIP) was performed using ChIP-IT express (Active Motif,
Rixensart, Belgium) (see Appendix S1) and the antibodies: mouse
monoclonal anti-human CTCF (BD Transduction Laboratories,
Lexington, KY, USA) and polyclonal rabbit anti-mouse IgG, as a
control (Abcam, Cambridge, UK). PCR primers used for LPR
ampliﬁcation were forward 5¢-GGGGTACCCCTGGCGTTGCCG
CTCTGAATGC-3¢ and reverse 5¢-CCGCTCGAGCGGAGGGAC
TGAGCTGGACAACCAC-3¢.
Electrophorectic mobility shift assays
The human recombinant CTCF protein was puriﬁed from baculo-
virus (Chernukhin et al. 2000). An oligonucleotide pair,
5¢-TCGACCCCTCGCAGTATCCCCCCTGCA-3¢ (100 ng) de-
signed as overhanging complementary strands, was annealed then
labelled with a-
32P dATP (speciﬁc activity 6000 Ci/mM) (Amer-
sham, Buckinghamshire, UK) using DNA Polymerase I, Large
(Klenow) Fragment (NEB, Hitchin, Hertfordshire, UK). Electro-
phoretic mobility shift analysis (EMSA) assays were performed as
previously described (Klenova et al. 2004).
Results
We have previously addressed the expression of the intronic
Stin2 VNTR cloned upstream of a minimal promoter in
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Roberts et al. 2007). The limitation of these studies was that
such vectors did not properly reﬂect the genome context. To
partially address this issue, we placed the SLC6A4 LPR
VNTR and Stin2 VNTR variants in more appropriate
locations within the reporter vector. Speciﬁcally the Stin2
alleles were cloned into an intronic site of the phRL reporter
vector and the LPR VNTR variants were cloned upstream of
the SV40 promoter (Fig. 1c). Although this placed the Stin2
VNTR within an intron mimicking the in vivo position, it is
important to acknowledge that these two domains are
15.5 kb apart in the human genome.
We had previously modiﬁed the phRL vector by intro-
duction of a unique enzyme site into the intron and utilised
this to address the function of intronic dopamine transporter
VNTR variants (Guindalini et al. 2006). We also generated
constructs using the same backbone but with only the LPR or
Stin2 variants cloned in their respective locations. This
allowed us to address not only the hypothesis that these two
SLC6A4 VNTR domains could act in cis but how combined
effects may differ from each independent domain alone, and
if interactions or synergisms were possible between these
VNTR domains that involved trans factors. Recently, an A/G
SNP in the l-allele of the LPR VNTR was reported to affect
mRNA expression levels of SLC6A4 gene (Hu et al. 2005;
Wendland et al. 2006), we therefore determined by sequence
analysis that the SNP in our clone was ‘A’. Functional
analysis was performed in primary cultures of rat prefrontal
cortex (PFC) primary culture, which were enriched for
neurons, because it has been reported that these cells express
the endogenous SLC6A4 gene (Fumagalli et al. 1996;
Hansson et al. 1998; Lebrand et al. 1998). However, because
of the mixed cell population of the PFC, a proportion of non-
neuronal glial cells are present even though cells were
prepared on poly-D-lysine coated plates to increase the
proportion of neuronal cells. Expression of the SLC6A4
mRNA in the rat PFC has been reported to peak early in
postnatal development at day 10 and gradually decrease to
weak expression at day 28, with no expression been recorded
in adult rats (Fumagalli et al. 1996; Hansson et al. 1998;
Lebrand et al. 1998). We conﬁrmed SLC6A4 mRNA
expression in our primary cultures by RT-PCR amplifying
a 460 bp cDNA fragment with primers in exons 1 and 4, to
eliminate the possibility of product ampliﬁed from contam-
inating DNA (Fig. 2). The cDNA of midbrain sections was
included in the RT-PCR as a positive control for SLC6A4
expression.
CTCF can bind to and regulate expression of both the LPR
and Stin2 alleles
We have previously demonstrated that the transcription factor
CTCF binds and differentially regulates the Stin2 VNTRs in
clonal cell lines (Klenova et al. 2004; Roberts et al. 2007).
In this study, we assessed the ability of the individual LPR
and Stin2 VNTRs to support reporter gene expression in rat
prefrontal cortical neuronal cells (PFC).
In this cell system, the l- and s-LPR alleles demonstrated
10- and 8-fold activation, respectively, over the phRLSV40
control (Fig. 3). In contrast, the Stin2.10 and Stin2.12 (the
Fig. 2 Agarose gel showing the reverse transcription PCR products of
the SLC6A4 gene ampliﬁed from sections of neonatal Wistar rat brain.
Lane 1: Mass ruler DNA Ladder; lane 2: SLC6A4 RT-PCR ampliﬁca-
tion from rat prefrontal cortex, amplifying a 460 bp cDNA fragment of
the expected size; lane 3: SLC6A4 RT-PCR ampliﬁcation from rat
midbrain; lane 4: negative control (water). Sizes of the ampliﬁed
fragments are indicated.
Fig. 1 Schematic representation of the SLC6A4 structure. (a) Sche-
matic representation of the SLC6A4 structure, highlighting the 5¢-LPR
and Stin2 VNTRs (white boxes); positioned relative to the transcrip-
tion start site (indicated as +1). Grey boxes: coding exons and black
boxes: non-coding exons. (b) The sequences of the long (l) and short
(s) alleles within the linked polymorphic region (LPR) of the human
serotonin transporter gene (SLC6A4) are shown on the left and right
respectively. Potential CTCF binding sites within the l- and s-alleles:
the best matches on the negative strand of the DNA are boxed based
on the CTCF ‘consensus’ identiﬁed via a genome-wide screen (Kim
et al. 2007) which is shown at the bottom of this panel. The size of
each base in the consensus is indicative of the probability of its
presence at a particular position within the 20 bp motif, with the most
restricted variation at 5, 6, 11, 14 and 15. (c) Cartoon illustrating rel-
ative positions of the SLC6A4 VNTRs in the reporter gene constructs
(not to scale). The single VNTR renilla luciferase reporter constructs
have either the s-o rl-allele alone upstream of the minimal SV40
promoter, or one of the intron 2 VNTR alleles (either Stin2.9, Stin2.10
or Stin2.12) located alone within a synthetic intron of the phRL vector
upstream of the renilla coding sequences. The dual constructs were
generated by cloning a combination of one of the 5¢-LPR alleles with
one of the Stin2 VNTR alleles in the same positions, respectively, as
used in the single reporter constructs.
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expression, over the phRLSV40 control (Fig. 4). However,
the rare nine copy allele, supported gene expression, showing
2.5-fold activation in comparison with the control,
phRLSV40 (Fig. 4).
Based on the CTCF ‘consensus’ motif, we identiﬁed
several potential CTCF binding sites within the LPR
(Fig. 1b). To conﬁrm CTCF binding to this region, we
performed ChIP in human JAr cells, as rodents do not
possess the same SLC6A4 polymorphism. In JAr cells, which
express the endogenous SLC6A4 gene and are heterozygous
for LPR alleles and contain the 10 and 12 copy variants of
the Stin2 VNTR, enrichment for CTCF binding was
observed for both alleles of the LPR, compared with the
IgG control (Fig. 5a).
To further conﬁrm the binding of CTCF to the 5¢-LPR we
performed EMSA using baculovirus puriﬁed CTCF
(Fig. 5b). The 5¢-LPR domain is much greater than the size
usually preferred for EMSA, thus we used an oligonucleotide
which corresponded to a repeat element of the VNTR
sequence that contained a CTCF binding motif. Two speciﬁc
complexes were observed, these were competed with
homologous competitor (Fig. 5b). Interestingly, only one of
these complexes was effectively competed by an oligonu-
cleotide sequence corresponding to one of the Stin2 VNTR
repeat elements, suggesting different afﬁnities for CTCF
binding.
We complemented the binding studies by addressing the
ability of the exogenous CTCF expressed from an expression
construct to modulate expression of either the LPR or Stin2
reporter gene cassettes. Co-expression of CTCF did not
Fig. 4 CTCF signiﬁcantly repressed the expression of the three allelic
variants of the Stin2 reporter construct in rat prefrontal cortical cells.
Rat prefrontal cortical cells were transfected as described in methods
with 1 lg of reporter gene construct plus either 1 lg of CTCF
expression vector or 1 lg of pGL3b, to standardise for total DNA
concentration; 20 ng of pMLuc-2 Fireﬂy luciferase was used as inter-
nal control. Bars represent the fold change in normalised renillin
activity supported by the VNTR compared with the phRL control under
basal conditions (black bars) or following CTCF over-expression
(white bars). Transfections were performed in triplicates in at least ﬁve
independent experiments and the mean normalised renillin values
were calculated together with the SEM represented by error bars.
One-way ANOVA using Dunnett’s t (two-sided) as a post hoc test indi-
cated that Stin2.10 and Stin2.12 supported no additional activity over
the phRL control (p = 0.814 and 0.981 respectively), whilst Stin2.9
supported reporter gene expression, 2.5-fold higher than the phRL
control (*p £ 0.001). Stin2.9 also showed signiﬁcant change in activity
compared with both Stin2.10 and Stin2.12 reporter constructs
p £ 0.001. Stin2 variants were signiﬁcantly repressed by CTCF over-
expression (
#p £ 0.05 and
##p £ 0.001).
Fig. 3 The SLC6A4 5¢-LPR alleles support similar levels of activity in
rat prefrontal cortical cells and CTCF does not regulate the activity of
either allele. Rat prefrontal cortical cells were transfected as described
in methods with 1 lg of reporter gene construct plus either 1 lgo f
CTCF expression vector or 1 lg of pGL3b, to standardise for total
DNA concentration; 20 ng of pMLuc-2 Fireﬂy luciferase was used as
internal control. Bars represent the fold change in normalised renillin
activity supported by the VNTR compared with the phRL control under
basal conditions (black bars) or following CTCF over-expression
(white bars). Transfections were performed in triplicates in at least ﬁve
independent experiments and the mean normalised renillin values
were calculated together with the SEM represented by error bars.
One-way ANOVA using Dunnett’s t (two-sided) as a post hoc test indi-
cated that both 5¢-LPR (l- and s-) alleles displayed a signiﬁcant
up-regulation compared with the phRL control (10 and 8-fold,
respectively, ***p £ 0.001), whereas no signiﬁcant difference was
observed when the two alleles were compared with each other
(p = 0.25, SE 1.018). Neither allele was signiﬁcantly affected by CTCF
over-expression.
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LPR variants (Fig. 3) but resulted in robust repression of all
three Stin2 variants (Fig. 4). The reporter cassette
(phRLSV40) without either VNTR, was unaffected by CTCF.
The dual LPR and Stin2 alleles support differential reporter
gene expression in cis
We hypothesised that as both VNTRs in the promoter and
intron 2 share at least one signal transduction pathway which
would be regulated by CTCF this might result in differential
reporter gene expression directed by distinct combinations of
the VNTRs. We therefore analysed activity supported by the
dual constructs containing either the l-o rs-allele in a
promoter position and a Stin2 VNTR located in the intron of
the reporter plasmid. These constructs demonstrated a
number of distinct expression proﬁles based on the genotype
of the VNTRs. Strikingly, the Stin2.10 and Stin2.12 variants
which did not support additional activity compared with the
phRLSV40 alone, when in conjunction with the s-variant
(S10 and S12) were capable of directing higher activity
compared with s-alone (p < 0.001) (Fig. 6a). However, the
Stin2.9 in combination with the LPR s-variant (S9),
displayed a similar pattern of expression to s-alone. These
data suggested a combinatorial rather than an additive
mechanism of gene regulation by the two VNTRs.
A complex expression pattern from the reporter was also
obtained when the Stin.2 variants were combined with the
LPR l-allele (Fig. 6b). The Dunnett’s post hoc test suggested
that L10 showed a signiﬁcant decrease in reporter gene
activity compared with l-alone, whilst neither L9 nor L12
showed signiﬁcant changes in activity compared with
l-alone. Our analysis also indicated that L12 signiﬁcantly
differed from both L10 and L9, reinforcing that the
combinatorial variation cannot be predicted from the indi-
vidual VNTR activity in this model.
We then tested the effects of CTCF on these constructs.
The Stin2 VNTR variants alone were all repressed by over-
expression of CTCF (Fig. 4), whilst CTCF had no effect on
the LPR constructs (Fig. 3). We therefore addressed the
potential regulation of the dual VNTR reporter gene
constructs by CTCF. In response to CTCF, the dual
constructs showed a variety of responses (Fig. 6). Speciﬁ-
cally, over-expression of CTCF signiﬁcantly repressed the
activity of L12 and S12 whilst no signiﬁcant effect was
observed with other dual constructs (Fig. 6). This would
suggest a distinct response of Stin2.12 irrelevant of the LPR
allele present. The perceived decrease in L10 over l-alone,
did not reach signiﬁcance in the presence of CTCF.
Discussion
Several groups including our own have demonstrated
differential effects of the SLC6A4 LPR and Stin2 VNTRs
on the expression of reporter genes in cell lines. Further, the
(a) (b)
Fig. 5 CTCF binds the 5¢-LPR VNTR of the SLC6A4 gene. (a) ChIP
analysis of the in vivo interaction of CTCF with the 5¢-LPR alleles.
ChIP analysis was performed as described in the methods section.
IgG was included as a control for non-speciﬁc background binding.
CTCF was found to bind both l- and s-alleles of the 5¢-LPR (upper and
lower bands respectively). (b) EMSA analysis of CTCF binding to a
repeat element of the 5¢-LPR. EMSA analyses were performed as
described in the methods section. CTCF puriﬁed from Baculovirus
showed that two speciﬁc protein/DNA complexes could be observed
(b, lane 1, closed arrows), which could be competed with homologous
competitor (b, lanes 2–4). Competitors were added from 10- to 100-
fold molar excess. However, only one of these complexes was com-
peted with the Stin2 oligonucleotide competitor (b, lanes 5–7, open
arrow). The complex indicated by asterisk possibly represents a non-
speciﬁc DNA–protein complex, because it did not compete with the
speciﬁc competitor.
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was cell type and promoter context dependent; this most
likely reﬂected the different complement of transcription
factors in these cells that could regulate the domains (Heils
et al. 1996; Lesch et al. 1996; Mortensen et al. 1999; Sakai
et al. 2002; Lovejoy et al. 2003; Klenova et al. 2004;
(a) (b)
Fig. 6 The SCL6A4 VNTR dual constructs support differential levels
of reporter gene expression and CTCF differentially regulates the
expression of these dual constructs in rat prefrontal cortical cells.
Rat prefrontal cortical cells were transfected as described in meth-
ods with 1 lg of reporter gene construct plus either 1 lg of CTCF
expression vector or 1 lg of pGL3b, to standardise for total DNA
concentration; 20 ng of pMLuc-2 Fireﬂy luciferase was used as
internal control. The renilla luciferase dual reporter constructs gen-
erated were a combination of either of the 5¢-LPR alleles cloned
upstream of the minimal SV40 promoter with either of the Stin2
VNTR alleles located within a synthetic intron of the phRL vector.
Bars represent the fold change in normalised renillin activity sup-
ported by the VNTR compared with the phRL control under basal
conditions (black bars) or following CTCF over-expression (white
bars). Transfections were performed in triplicates in at least three
independent experiments and the mean normalised renillin values
were calculated together with the SEM represented by error bars.
One-way ANOVA using Dunnett’s t (two-sided) as a post hoc test
indicated that (a) Both S10 and S12 were capable of directing
signiﬁcantly higher activity compared with s alone (p < 0.001 for
both), whereas S9 did not display signiﬁcant difference compared
with the s construct alone (p = 0.72) *p £ 0.05 and **p £ 0.001. (b)
L10 showed a signiﬁcant decrease in reporter gene activity com-
pared with l-alone (p = 0.024), whilst neither L9 nor L12 showed
signiﬁcant change in activity compared with l-alone (p = 0.515 and
0.312 respectively). CTCF displayed differential activity on the dual
reporter constructs by signiﬁcantly repressing the activity of (a) S12
and (b) L12 (
##p £ 0.001 and
#p £ 0.05), whilst no signiﬁcant effect
was observed with the other constructs as illustrated by the
post hoc test applied.
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determined as predisposing factors for various psychiatric
disorders including unipolar and bipolar depression (Cho
et al. 2005; Cervilla et al. 2006), anxiety (Lesch et al. 1996;
Hariri et al. 2002) and predisposition to obsessive compul-
sive disorder (Bengel et al. 1999). However, these domains
have also been disputed as susceptibility factors and
meta-analysis has raised further questions (Cho et al. 2005;
Lasky-Su et al. 2005).
To the authors’ knowledge, with the exception of Kaiser
et al. (2002) and Hranilovic et al. (2004) all studies in
the literature have focused on the effect of only one of the
SLC6A4 VNTRs, either LPR or Stin2, on expression of the
SLC6A4 and association with affective disorders (Lesch et al.
1996; Bengel et al. 1999; Hariri et al. 2002; Cho et al.
2005). Here we demonstrate, in rat neuronal cells, which
express the endogenous SLC6A4 gene that the 5¢-LPR and
Stin2 VNTRs within the SLC6A4 gene, are at least in part, are
likely to be on the same signalling pathway regulated by
CTCF. We further demonstrate that the 5¢-LPR and Stin2
VNTRs can support differential gene expression when
analysed in concert using constructs designed to mimic their
endogenous positions in the gene, albeit as indicated
previously these two domains are 15.5 kb apart in the human
genome. However, CTCF is known to mediate looping
between distant DNA elements, therefore the mechanistic
basis of regulation by CTCF in vivo and in the reporter
system used may be similar and rely on loop formation
between two CTCF sites (Phillips and Corces 2009; Zlata-
nova and Caiafa 2009). However as the functional outcomes
from the dual constructs containing l- and s-variants are
different (Fig. 6), the properties of such hypothetical loops
would be expected to vary. One possible scenario would be
that CTCF may utilise different combinations of its zinc
ﬁngers at different binding sites thus releasing different
surfaces for interaction with protein partners (Ohlsson et al.
2001). This, in turn, may result in the formation of distinct
functional high order DNA–protein complexes leading to
different functional outcomes (Wallace and Felsenfeld 2007).
This will need to be investigated further.
Although the VNTRs are likely to function in the adult
CNS in response to challenge we have previously demon-
strated that in a transgenic mouse model the Stin2 variants
supported differential reporter gene expression during devel-
opment in the CNS region initially involved in serotonergic
lineage (MacKenzie and Quinn 1999). Furthermore, there are
also increasing suggestions that the role of the SLC6A4
polymorphisms may be more pronounced during embryo-
genesis and development, thus raising the possibility that
disrupting normal maturation of certain neuronal networks
critical for normal adult functions, will inﬂuence behaviour
and increase vulnerability to psychiatric disorders in adults
(Caspi et al. 2003; Ansorge et al. 2004; Parsey et al. 2006).
This might be relevant for our current study as we utilised rat
neonate prefrontal cortical cells which in vivo demonstrate
differential SLC6A4 expression in the rat in early postnatal
period (Fumagalli et al. 1996; Hansson et al. 1998; Lebrand
et al. 1998), therefore the functional consequence of these
VNTR polymorphisms could to be support differential
expression of the SLC6A4 gene at this point based on
genotype.
When the LPR variants were analysed individually, there
was no differential activity between the two variants, l- and
s-, on reporter gene expression levels (Fig. 3). This agrees
with previous studies in COS-7, PC-12 and raphe-nucleus-
derived RN46A cells which found that these VNTR variants
did not support differential expression (Willeit et al. 2001;
Kaiser et al. 2002; Sakai et al. 2002). Others, however, have
demonstrated that these alleles did support differential
activity (Heils et al. 1996; Lesch et al. 1996). Similar
conﬂicting data exist based on mRNA analyses (Lesch et al.
1996; Mortensen et al. 1999; Hranilovic et al. 2004; Lim
et al. 2006). Therefore, studies on the abilities of the LPR
VNTR variants to support differential gene expression, like
the clinical correlations themselves do not agree. These
contradictory reports may arise from differences in experi-
mental parameters (reviewed in Haddley et al. 2007) or
demonstrate tissue-speciﬁc factors or variation in the
concentration of speciﬁc transcription factors in a particular
cell type. The latter is consistent with our data on manip-
ulation of CTCF concentration altering reporter gene
expression supported by the Stin2 VNTR in human embry-
onic kidney cells, COS-7 and JAr cells (Klenova et al. 2004;
Roberts et al. 2007). Indeed in this study, CTCF repressed
the activity driven by the Stin2 variants in the neuronal
cultures, when cloned within the synthetic intron construct,
which contrasted with our previous data in non-neuronal cell
lines in which CTCF increased activity from the Stin2
variants when cloned upstream of the SV40 promoter
(Klenova et al. 2004; Roberts et al. 2007). Without rigorous
testing of all combinations and manipulation of transcription
factor concentration we can however state that CTCF
concentration will modulate VNTR function.
Many previous studies have associated one or other of
these individual SLC6A4 VNTRs with affective disorders
(Lesch et al. 1996; Bengel et al. 1999; Hariri et al. 2002;
Cho et al. 2005). We have now demonstrated that these two
VNTRs from the SLC6A4 gene, in the context of the same
reporter system, support differential gene expression based
on copy number of both VNTRs. Furthermore, the capability
of the dual VNTR constructs to support differential gene
expression, under basal growth conditions and in response to
over-expression of CTCF, would suggest they act in a
manner which is simply not additive from the action of the
individual construct in the same cell. For example, the LPR
s-allele supported an approximate eightfold increase over the
phRLSV40 control (Fig. 3) whilst the Stin2.12 allele did not
support additional activity over the control when constructs
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in the dual construct, a 17-fold increase over phRLSV40
was observed (Fig. 6). These analyses may explain, in part,
some of the contradictory reports in the literature and
indicate that the abilities of both of the VNTRs in the
SLC6A4 gene to act in cis should be considered when
addressing their correlation to speciﬁc neurological disor-
ders, furthermore the combined genotype of an allele may
mediate a response to a particular drug or stimulus. As both
domains are transcriptional regulators this easily allows for
a gene–environment parameter to be factored into a
correlation of the VNTRs with a speciﬁc condition. It is
possible that the impact of the genotype only becomes
apparent following exposure to environmental factors, or in
response to a particular stimulus e.g., stresses or drugs
(Murphy et al. 2001). For example, various studies have
demonstrated that carriers of the s-allele of the 5¢-LPR are
more likely to develop an episode of major depression only
following stressful life events (Bennett et al. 2002; Champ-
oux et al. 2002; Barr et al. 2003; Caspi et al. 2003).
Clearly such events could alter the transcription factor
complement in the cell thus altering VNTR mediated
expression; this could be signiﬁcant both in the adult and
during development. Therefore, challenges altering the
function of these VNTRs could ultimately inﬂuence an
individual’s vulnerability to environmental stress and ten-
dency to develop psychiatric disorders by altering both the
level of expression of the SLC6A4 gene or perhaps event
the tissue-speciﬁc expression during development. Such
parameters should be taken into consideration in the design
of psychiatric genetics and association studies (Caspi et al.
2003; Parsey et al. 2006). Our data on the combinatorial
potential of the VNTRs is consistent with analysis of
SCL6A4 expression in lymphoblast cell lines which failed
to ﬁnd a correlation with the LPR VNTR, but did ﬁnd
evidence for a combined effect of LPR and Stin2 VNTRs
(Hranilovic et al. 2004). These data may encourage a better
appreciation of how different variants could function in
concert in vivo to allow better statistical correlations of
these domains with a particular disorder by addressing
multiple variants on the same allele. Indeed for SLC6A4
there may be other promoter variants that modulate the
activity of the VNTRs.
An important point from our analysis is perhaps not the
absolute levels of reporter gene observed, nor indeed
whether they are repressed or activated by over-expression
of CTCF, but rather that the potential for differential gene
expression supported by combinations of the speciﬁc
variants exists. The action of CTCF highlights the potential
role for epigenetic modulation of expression of SLC6A4
gene via these VNTRs, which could result in long-term
differences in gene expression. Recently, Philibert et al.
(2007) suggested that mechanisms linking the SLC6A4
polymorphisms vulnerability to epigenetic effects should be
considered in association studies, as they demonstrated
methylation of a CpG island in the 5¢-region of the SLC6A4
signiﬁcantly affects expression of the SLC6A4 gene and that
the extent of that effect is dependent on the 5¢-LPR
genotype. In this respect, the action of CTCF to modulate
the activity of CpG domains might become relevant to future
studies.
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